CureVac
Ann-Kathrin Widmann is an experienced professional in quality assurance and pharmaceutical technology. Currently serving as a Quality Assurance Manager at CureVac since December 2022, Ann-Kathrin has a strong academic background with a PhD candidacy in Pharmaceutical Technology and Biopharmacy at Eberhard Karls Universität Tübingen, where a thesis focused on the extraction of Curcuma longa L. using supercritical CO2 was completed. Ann-Kathrin has also worked as a Research Associate and Assistant Teacher, engaging in university teaching that included seminars and laboratory work supervision on various dosage forms and biopharmacy. Prior to this, Ann-Kathrin gained practical experience through internships at KVP Pharma+Veterinär Produkte GmbH and Schwabenland Apotheke, after earning a Staatsexamen in Pharmacy from the University of Tübingen.
This person is not in the org chart
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.